[1]赵珍珍,史艳平,邱 锐,等.清热活血方联合阿奇霉素治疗儿童肺炎支原体肺炎临床研究[J].陕西中医,2021,(5):616-619.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.018]
　ZHAO Zhenzhen,SHI Yanping,QIU Rui,et al.Effect of Qingre Huoxue decoction with Azithromycin on mycoplasma pneumoniae pneumonia in children[J].,2021,(5):616-619.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.018]
点击复制

清热活血方联合阿奇霉素治疗儿童肺炎支原体肺炎临床研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年5期
页码:
616-619
栏目:
临床研究
出版日期:
2021-05-05

文章信息/Info

Title:
Effect of Qingre Huoxue decoction with Azithromycin on mycoplasma pneumoniae pneumonia in children
作者:
赵珍珍1; 史艳平1; 2; 邱 锐1; 汪 琼2; 李春阳2; 李 隽2; 田纪凤2; 吉 慧2; 李 霞2
(1.陕西中医药大学,陕西 咸阳 712000; 2.西安市儿童医院,陕西 西安710003)
Author(s):
ZHAO Zhenzhen; SHI Yanping; QIU Rui; WANG Qiong; LI Chunyang; LI Jun; TIAN Jifeng; JI Hui; LI Xia
(Shaanxi University of Chinese Medicine,Xianyang 712000,China)
关键词:
肺炎支原体肺炎;  儿童;  清热活血方;  炎性因子;  白介素-6
Keywords:
Mycoplasma pneumoniae pneumonia;  Children;  Qingre Huoxue decoction;  Inflammatory factor;  Interleukin-6
分类号:
R 725.6
DOI:
DOI:10.3969/j.issn.1000-7369.2020.05.018
文献标志码:
A
摘要:
目的:探讨清热活血方联合阿奇霉素治疗儿童肺炎支原体肺炎(MPP)的临床疗效。方法:将134例患儿按随机数字表法分为对照组及治疗组,对照组67例给予阿奇霉素及对症支持治疗,治疗组67例在对照组基础上给予清热活血方治疗。对比分析两组患儿临床疗效及治疗前后血清炎性因子白介素-6(IL-6)、白介素-4(IL-4)、白介素-8(IL-8)及肿瘤坏死因子-α(TNF-α)水平、临床症状及肺部体征消失时间、C反应蛋白(CRP)、血沉(ESR)、白细胞计数、肺炎支原体(MP)血清学试验改善情况。结果:治疗组总有效率为89.55%,优于对照组的74.63%,差异具有统计学意义(P<0.05); 治疗组住院时间、临床症状及肺部体征消失时间与对照组相比,差异具有统计学意义(均P<0.05); 治疗后,两组血清炎性因子IL-6、IL-4、IL-8及TNF-α、CRP、ESR及MP血清学试验与治疗前相比均下降,且治疗组低于对照组(P<0.05); 但在治疗前后白细胞计数差异无统计学意义(P>0.05)。结论:清热活血方联合阿奇霉素治疗儿童MPP疗效显著,其机制可能与降低炎性因子水平,改善炎性指标有关。
Abstract:
Objective:To investigate the clinical efficacy of Qingre Huoxue decoction combined with azithromycin in the treatment of mycoplasma pneumonia in children.Methods:The 134 children were divided into control group and treatment group by random number table method.67 children in the control group were given azithromycin and symptomatic support treatment,and 67 children in the treatment group were given Qingre Huoxue decoction on the basis of the control group.The clinical efficacy,serum levels of inflammatory factors IL-6,IL-4,IL-8 and TNF-α,disappearance time of clinical symptoms and pulmonary signs,C-reactive protein,erythrocyte sedimentation rate,white blood cell count,and improvement of mycoplasma pneumoniae serology before and after treatment in the two groups were compared and analyzed.Results:The total effective rate in the treatment group was 89.55%,which was better than 74.63% in the control group,and the difference was statistically significant(P<0.05).Compared with the control group,the hospitalization time,clinical symptoms and disappearance time of pulmonary signs in the treatment group were statistically significant(all P<0.05).After treatment,serum inflammatory factors IL-6,IL-4,IL-8,TNF-α,C-reactive protein,erythrocyte sedimentation rate and mycoplasma pneumoniae in both groups decreased compared with before treatment,and the treatment group was lower than the control group(P<0.05).However,there was no statistically significant difference in WBC count before and after treatment(P>0.05).Conclusion:Qingre Huoxue decoction combined with azithromycin has a significant effect on mycoplasma pneumoniae in children,and its mechanism may be related to lowering the levels of inflammatory factors,and improving the inflammatory indicators.

参考文献/References:

[1] 李 静,刘长山,王雪艳.儿童肺炎支原体肺炎临床特点及重症危险因素分析[J].天津医科大学学报,2019,25(4):396-399.
[2] 房亚菲,刘丽娟,霍 晨.儿童社区获得性肺炎的流行特征和临床表现及病原菌调查[J].中华医院感染学杂志,2020,30(5):752-756.
[3] Narita M.Classification of extrapulmonary manifestations due to mycoplasma pneumoniae infection on the basis of possible pathogenesis [J].Frontiers in Microbiology,2016(7):23.
[4] 归巧娣,施瑞洁,张向阳,等.西安地区2837例儿童肺炎支原体感染及耐药调查研究[J].陕西医学杂志,2018,47(2):265-267.
[5] 贺金娥,李 静,高春燕.肺炎支原体肺炎患儿血清细胞因子IL-6、TNF-α检测及临床价值[J].陕西医学杂志,2015,44(9):1151-1152,1172.
[6] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:124-129.
[7] Kumar S.Mycoplasma pneumoniae:A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections[J].Indian J Med Res,2018,147(1):23-31.
[8] 韩姝奕,杨淑兰,胡景伟.儿童难治性支原体肺炎预测标志物的研究进展[J].内蒙古医学杂志,2019,51(1):38-40.
[9] Dubey A,Izakelian L,Ayaub EA,et al.Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo[J].Immunol Cell Biol,2018,96(3):257-272.
[10] Karakioulaki M,Stolz D.Biomarkers in pneumonia-beyond procalcitonin[J].Int J Mol Sci,2019,20(8):2004.
[11] Chou SC,Ko HW,Lin YC.CRP/IL-6/IL-10 single-nucleotide polymorphisms correlate with the susceptibility and severity of community-acquired pneumonia[J].Genet Test Mol Biomarkers,2016,20(12):732-740.
[12] Li G,Fan L,Wang Y,et al.High co-expression of TNF-alpha and CARDS toxin is a good predictor for refractory mycoplasma pneumoniae pneumonia[J].Mol Med,2019,25(1):38.
[13] 余丽丽,赵德育.肺炎支原体肺炎发病机制研究进展[J].中国实用儿科杂志,2017,32(3):234-238.
[14] Reynolds CJ,Quigley K,Cheng X,et al.Lung defense through IL-8 carries a cost of chronic lung remodeling and impaired function[J].Am J Respir Cell Mol Biol,2018,59(5):557-571.
[15] Ali A,Abbasi AS,Amjad T,et al.Erythrocyte sedimentation rate and C-reactive protein as marker of acute versus chronic medical conditions[J].Journal of Ayub Medical College,2019,31(1):39-45.
[16] 贺 辉,刘正艳,梁丽娜,等.宣肺清毒汤治疗小儿支原体肺炎疗效及对患者血清炎性因子表达水平的研究[J].陕西中医,2019,40(5):627-630.
[17] Parnham MJ,Erakovic HV,Giamarellos BE,et al.Azithromycin:Mechanisms of action and their relevance for clinical applications[J].Pharmacol Ther,2014,143(2):225-245.
[18] Golkar T,Zielinski M,Berghuis AM.Look and outlook on enzyme-mediated macrolide resistance[J].Front Microbiol,2018(9):1942.
[19] 谭 丹,姜之炎.中医药治疗儿童肺炎支原体肺炎的机制研究进展[J].中华中医药学刊,2018,36(6):1403-1406.
[20] 邹武军,郭焕利,李晓丽,等.麻甘颗粒联合阿奇霉素治疗小儿支原体肺炎疗效研究[J].陕西中医,2019,40(11):1582-1585,1589.

相似文献/References:

[1]贺 辉,刘正艳,梁丽娜,等.宣肺清毒汤治疗小儿支原体肺炎疗效及对患者血清炎性因子表达水平的研究[J].陕西中医,2019,(5):627.
　HE Hui,LIU Zhengyan,LIANG Lina,et al.Effect of Xuanfei Qingdu decoction on children of mycoplasma pneumonia and its influence on expression level of serum inflammatory factors[J].,2019,(5):627.
[2]陈 悦,尚莉丽.从“伏毒”学说论治儿童支气管哮喘[J].陕西中医,2021,(3):350.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.021]
[3]刘 芳,杨 雪,张肖瑾.加味五虎汤联合孟鲁司特钠治疗儿童咳嗽变异性哮喘临床观察[J].陕西中医,2021,(5):612.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.017]
　LIU Fang,YANG Xue,ZHANG Xiaojin.Clinical observation of modified Wuhu decoction combined with Montelukast sodium in the treatment of cough variant asthma in children[J].,2021,(5):612.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.017]
[4]许凤丽,纪 红,宫为大,等.鼠神经生长因子穴位注射联合Bobath法治疗运动发育迟缓患儿临床疗效[J].陕西中医,2021,(5):650.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.027]
　XU Fengli,JI Hong,GONG Weida,et al.Effect of acupoint injection of NGF combined with Bobath method in the treatment of children with motor development retardation[J].,2021,(5):650.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.027]
[5]李 宁,黄怡玲,姚翠婵.十味败毒汤治疗儿童特异性皮炎疗效及对患儿睡眠的影响[J].陕西中医,2021,(7):873.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.015]
[6]冯欣欣,朱学亮,张全锁,等.头针联合单唾液酸四己糖神经节苷酯钠治疗小儿痉挛性瘫痪疗效及对患儿血清神经生长因子、内皮素水平影响[J].陕西中医,2021,(7):948.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.037]
[7]赵 娜,高 爽,李桂华,等.中医药治疗腺体肥大临床研究进展[J].陕西中医,2021,(7):974.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.043]
[8]郭 宁,李亚平.儿童抽动障碍中医治疗研究进展[J].陕西中医,2021,(7):983.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.046]
[9]冉瑞莹,尹 一,闫永彬.从瘀热互结论治儿童腺样体肥大[J].陕西中医,2021,(10):1436.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.029]
[10]王小利,罗欢欢,洪浩然.补髓柔筋推拿配合平衡肌力训练对小儿痉挛型脑瘫下肢功能及表面肌电图的影响[J].陕西中医,2022,(7):946.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.033]
　WANG Xiaoli,LUO Huanhuan,HONG Haoran.Supplementing-marrow kneading-tendon massage combined with balance muscle strength training on children with spastic cerebral palsy and its influences on lower limb function,surface electromyography[J].,2022,(5):946.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.033]

备注/Memo

备注/Memo:
基金项目:西安市科技计划项目[2019114613YX001SF034(8)]; 西安市卫生与计划生育委员会科研项目(J201902035); 西安市中医药管理局科研项目(SZL201915); 西安市卫生健康委员会课题(2020YB31)
更新日期/Last Update: 2021-05-10